|
Home : Unsafe Drugs : Avandia : News Articles : Questor share tip: GlaxoSmithKline is a solid yield play and is set for a return to growth - Telegraph Questor share tip: GlaxoSmithKline is a solid yield play and is set for a return to growth - Telegraph
Also, the numbers were hit by the loss of revenue from its Avandia diabetes medicine, which the company has stopped promoting because of an increased risk of heart attacks, and generic competition to its Valtrex treatment for genital herpes. Related Articles Glaxo ventures into fragile markets with Somalian sale 30 Apr 2011 Glaxo profit helped by disposals as ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




